These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8261257)

  • 1. Controversies in meta-analysis: the case of the trials of serum cholesterol reduction.
    Thompson SG
    Stat Methods Med Res; 1993; 2(2):173-92. PubMed ID: 8261257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical methods for the meta-analysis of cluster randomization trials.
    Donner A; Piaggio G; Villar J
    Stat Methods Med Res; 2001 Oct; 10(5):325-38. PubMed ID: 11697225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bivariate approach to meta-analysis.
    Van Houwelingen HC; Zwinderman KH; Stijnen T
    Stat Med; 1993 Dec; 12(24):2273-84. PubMed ID: 7907813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analytic interval estimation for standardized and unstandardized mean differences.
    Bonett DG
    Psychol Methods; 2009 Sep; 14(3):225-38. PubMed ID: 19719359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials.
    Phung OJ; Makanji SS; White CM; Coleman CI
    J Am Diet Assoc; 2009 May; 109(5):865-73. PubMed ID: 19394473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explaining heterogeneity in meta-analysis: a comparison of methods.
    Thompson SG; Sharp SJ
    Stat Med; 1999 Oct; 18(20):2693-708. PubMed ID: 10521860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accounting for heterogeneity in meta-analysis using a multiplicative model-an empirical study.
    Mawdsley D; Higgins JP; Sutton AJ; Abrams KR
    Res Synth Methods; 2017 Mar; 8(1):43-52. PubMed ID: 27259973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A likelihood approach to meta-analysis with random effects.
    Hardy RJ; Thompson SG
    Stat Med; 1996 Mar; 15(6):619-29. PubMed ID: 8731004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios.
    Koller MT; Stijnen T; Steyerberg EW; Lubsen J
    J Clin Epidemiol; 2008 Apr; 61(4):365-72. PubMed ID: 18313561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ; Economopoulos K
    Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures.
    Johnston BC; Thorlund K; da Costa BR; Furukawa TA; Guyatt GH
    J Clin Epidemiol; 2012 Aug; 65(8):817-26. PubMed ID: 22652347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
    Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
    Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quasi-empirical Bayes methodology for improving meta-analysis.
    Saleh AK; Hassanein KM; Hassanein RS; Kim HM
    J Biopharm Stat; 2006; 16(1):77-90. PubMed ID: 16440838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why sources of heterogeneity in meta-analysis should be investigated.
    Thompson SG
    BMJ; 1994 Nov; 309(6965):1351-5. PubMed ID: 7866085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.